US · Healthcare

Trevi Therapeutics Inc (TRVI)

Biotechnology

Trevi Therapeutics Inc (TRVI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TRVI

P/E ratio

25.00

Trevi Therapeutics Inc (TRVI) — FAQ

What is TRVI's P/E ratio?

The price-to-earnings (P/E) ratio for Trevi Therapeutics Inc (TRVI) is 25.00 (data as of 2026-05-23).

Does Trevi Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Trevi Therapeutics Inc (TRVI). Check the MyAverix Finance app for the latest dividend data.

What sector is Trevi Therapeutics Inc in?

Trevi Therapeutics Inc (TRVI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is TRVI listed on?

TRVI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)